| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/12/2003 | EP1235809B1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments |
| 11/12/2003 | EP1233973B1 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 11/12/2003 | EP1229909B1 Transdermal delivery of lasofoxifene |
| 11/12/2003 | EP1216057B1 Stable calcitriol solution for packaging in vials |
| 11/12/2003 | EP1214062B1 Use of nicotinic acetylcholine receptor agonists for the preparation of a medicament for the treatment of dry eye disease |
| 11/12/2003 | EP1206444B1 Compounds that inhibit tryptase activity |
| 11/12/2003 | EP1206265B1 Src kinase inhibitor compounds |
| 11/12/2003 | EP1200412B1 Imidazole antiproliferative agents |
| 11/12/2003 | EP1181286B1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
| 11/12/2003 | EP1178819B1 Glutathione reductase for therapy and prophylaxis of aids |
| 11/12/2003 | EP1159005B1 Pharmaceutical combination of antiviral agents |
| 11/12/2003 | EP1146895B1 Thrombopoietin compositions for increasing circulating platelets |
| 11/12/2003 | EP1140937B1 Antiviral nucleoside analogues |
| 11/12/2003 | EP1133308B1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases |
| 11/12/2003 | EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors |
| 11/12/2003 | EP1094815B1 Farnesyl protein transferase inhibitors for treating arthropathies |
| 11/12/2003 | EP1087750B1 Pharmaceutical formulations for aerosols with two or more active substances |
| 11/12/2003 | EP1058549A4 THROMBIN OR FACTOR Xa INHIBITORS |
| 11/12/2003 | EP1032390B1 Anaesthetic formulation |
| 11/12/2003 | EP1019373B1 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidine derivatives as human nk3 receptor selective antagonists |
| 11/12/2003 | EP1017278B1 Use of quaternary carboxylic acid alkanolamine ester salts as microbicide agents |
| 11/12/2003 | EP1007524B1 Indole derivatives as 5-ht1b and 5-ht1d agonists |
| 11/12/2003 | EP0999819B1 Physiological combination of active substances to enhance the skin's defenses against noxious agents |
| 11/12/2003 | EP0996618B1 Endothelin antagonists: n- 2'- (4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl) 1,1'-biphenyl]-2-yl]methyl] -n,3,3-trimethylbutanamide and n-(4,5-dimethyl-3-isoxazolyl) -2'- (3,3-dimethyl-2-oxo-1-pyrrolidinyl) methyl] -4'-(2-oxazolyl) 1,1'-biphenyl]-2-sulfonamide and salts thereof |
| 11/12/2003 | EP0991618B1 Selective thyroid hormone analogs |
| 11/12/2003 | EP0986403B1 Composition with extended shelf-life storage comprising cyclodextrin and drugs or prodrugs that decompose to water-insoluble components |
| 11/12/2003 | EP0979087B1 Analgesic combination |
| 11/12/2003 | EP0975599B1 Subtituted isoquinolines as ultra short acting neuromuscular blockers |
| 11/12/2003 | EP0970100B1 Benzimidazole derivatives |
| 11/12/2003 | EP0906078B1 Topical use of tempol in the prevention of photoaging |
| 11/12/2003 | EP0897390B1 Human tumor necrosis factor delta and epsilon |
| 11/12/2003 | EP0882067B1 Methods of treating vascular disease with tnf antagonists |
| 11/12/2003 | EP0871454B1 Phosphorous-containing cysteine and serine protease inhibitors |
| 11/12/2003 | EP0861243B1 Heterocyclic compounds as bradykinin antagonists |
| 11/12/2003 | EP0847272B1 LIPOSOMAL p-ETHOXY OLIGONUCLEOTIDES |
| 11/12/2003 | EP0818987B1 Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions |
| 11/12/2003 | EP0817623B1 Medicaments for the selective treatment of tumour tissues |
| 11/12/2003 | EP0804163B1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
| 11/12/2003 | EP0781130B1 Fatty acid primary amide for use in inducing sleep |
| 11/12/2003 | EP0760657B1 Novel potent inducers of terminal differentiation and methods of use thereof |
| 11/12/2003 | EP0759759B1 P75 tnf receptor promoters |
| 11/12/2003 | EP0752987B1 Pyrimidinyl derivatives as interleukin inhibitors |
| 11/12/2003 | EP0583378B1 Combined calcium and vitamin d supplements |
| 11/12/2003 | EP0517850B1 Compositions and methods of treatment of sympathetically maintained pain |
| 11/12/2003 | CN2586281Y Intelligent series charger |
| 11/12/2003 | CN1455779A Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase |
| 11/12/2003 | CN1455778A Tartrate salt of thiazolidinedione derivative |
| 11/12/2003 | CN1455777A Tartrate salts of thiazolidinedione derivative |
| 11/12/2003 | CN1455772A Preventive or remedial agent for allergic disease and medical water-based liquid preparation, eye drop and nasal drop |
| 11/12/2003 | CN1455771A Cyclic amine phenyl Beta-3 adrenergic receptor agonists |
| 11/12/2003 | CN1455770A (2-azabicyclo [2,2,1] hept-7-yl] methanol derivatives as nicotinic acetylcholine receptor agonisis |
| 11/12/2003 | CN1455769A Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists |
| 11/12/2003 | CN1455767A Substituted phenylcyclohexane carboxylic acid amides and use thereof |
| 11/12/2003 | CN1455766A Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
| 11/12/2003 | CN1455765A Novel retinoid derivatives and production method thereof and anti-cancer pharmaceutical composition comprising same |
| 11/12/2003 | CN1455691A Pharmaceutical compositions |
| 11/12/2003 | CN1455681A Contraception process and administration for same |
| 11/12/2003 | CN1455679A Use of melagatran for manufacture of medicament for treatment of ischemic disorders |
| 11/12/2003 | CN1455672A Use of 2-methylene-19-Nor-20(s)-1 alpha, 25-dihydroxy vitamin D3 to increase bone strength |
| 11/12/2003 | CN1455671A Methods for delaying recurrence of herpes virus symptoms |
| 11/12/2003 | CN1455670A Combination of lipoic acids and conjugated acids for treating diabetic disorders |
| 11/12/2003 | CN1455669A Esmolol formulation |
| 11/12/2003 | CN1455667A Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 11/12/2003 | CN1455663A Novel aerosol formulation containing polar fluorinated molecule |
| 11/12/2003 | CN1454900A Glucose and insulin response element |
| 11/12/2003 | CN1454895A Use of 2',4'-dihydroxy-6'-methoxy-3',5'-dimethyl chalcone for preparing anticancer medicine |
| 11/12/2003 | CN1454888A Rapid-dissoved ambroxol salt and preparing method thereof |
| 11/12/2003 | CN1454656A Medicine for curing leuconychia and hand-foot ringworm and preparing method thereof |
| 11/12/2003 | CN1454616A Medicine for curing haemorrhoids |
| 11/12/2003 | CN1454615A Sesquiterpene injection, and preparing method and use thereof |
| 11/12/2003 | CN1454607A Medicine for curing cervicitis and preparing method thereof |
| 11/12/2003 | CN1454602A High water-soluble povidone-iodine cream |
| 11/12/2003 | CN1454601A Eye drops comprising liquaemin or potassium heparin and preparing method thereof |
| 11/12/2003 | CN1454600A Hiliezdum fast-release tablet and preparing method thereof |
| 11/12/2003 | CN1454599A Rhodiola total tanning matter extract and use for preparing medicine for curing senile dementia |
| 11/12/2003 | CN1454598A Compound phytosterol with serum cholesterol-reducing action and preparing process thereof |
| 11/12/2003 | CN1454597A Oral slow-release and controlled-release preparation for curing depression |
| 11/12/2003 | CN1454596A Compound medicine of ginkgo leaf extract and dipyridamole and preparing method thereof |
| 11/12/2003 | CN1454595A Pharmaceutical composition comprising pyrroloquinoline quinone for curing and preventing fatty liver |
| 11/12/2003 | CN1454594A Nicardipine hydrochloride controlled-release preparation |
| 11/12/2003 | CN1454593A Use of total bryostatin for preparing medicine for anti SARS coronavirus |
| 11/12/2003 | CN1454592A Medical use of andrographolide and its derivatives |
| 11/12/2003 | CN1454591A Encapsulated preparation of sodium decanoy acetaldehyde |
| 11/12/2003 | CN1454590A Ethylenediamine diaceturate lyophilized powder injection and preparing method thereof |
| 11/12/2003 | CN1454589A Coenzyme Q10 aseptic freee-drying preparation for injection and its preparing method |
| 11/12/2003 | CN1127560C Gamma-linolenic acid replenishing additive for food, medicine and cosmetics |
| 11/12/2003 | CN1127514C Antineoplastic peptides |
| 11/12/2003 | CN1127513C Phosphonic acid derivatives with metallopeptidase inhibitory activity |
| 11/12/2003 | CN1127512C Acylated enol derivatives of alpha-ketoesters and alpha-ketoamides |
| 11/12/2003 | CN1127508C Polyene antibiotics 3874 H1-H6, preparation method and use thereof |
| 11/12/2003 | CN1127506C New compound for treating asgnodia |
| 11/12/2003 | CN1127502C Salts of paroxetine |
| 11/12/2003 | CN1127500C Substituted bisindolymaleimides for inhibition of cell proliferation |
| 11/12/2003 | CN1127499C Novel form of irbesartan, Methods of obtaining said form and pharmaceutical compositions containing same |
| 11/12/2003 | CN1127497C Benzothiepine-1, 1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 11/12/2003 | CN1127494C Neuaminic acid dervatives, their preparation and their medical use |
| 11/12/2003 | CN1127493C 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring |
| 11/12/2003 | CN1127490C Cyclohexane derivatives difunctionalised in1,4 as ligands of 5-HT1A receptors |
| 11/12/2003 | CN1127488C Compouds with growth hormone releasing properties |
| 11/12/2003 | CN1127487C Phthalazinone and its use, and drug containing same |